Foghorn Therapeutics Inc.·4

Jan 25, 4:03 PM ET

Costa Carlos 4

4 · Foghorn Therapeutics Inc. · Filed Jan 25, 2024

Insider Transaction Report

Form 4
Period: 2024-01-24
Costa Carlos
Chief People Officer
Transactions
  • Award

    Stock Option (right to buy)

    2024-01-24$3.06/sh+90,000$275,40090,000 total
    Exercise: $3.06Exp: 2034-01-23Common Stock (90,000 underlying)
Footnotes (1)
  • [F1]The option vests as to 25% of the underlying shares of common stock on January 24, 2025, and thereafter at a rate of 6.25% of the underlying shares on the first day of each calendar quarter.

Documents

1 file
  • 4
    primarydocument.xmlPrimary

    PRIMARY DOCUMENT